Tel: +44 (0) 1896 664000 | Fax: +44 (0) 1896 664001
About ProStrakan ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets. With approximately 200 people employed in the Company's operations, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe. In R&D, the Company's Development group is located at Galashiels in Scotland. In June 2005, ProStrakan completed its initial public offering (IPO) of shares to become listed on the London Stock Exchange. Aim Our aim is to alleviate the often distressing symptoms associated with hitherto poorly treated conditions.We will achieve this by introducing novel and effective prescription medicines to the market, in the process creating a significant international pharmaceutical business. In addition to rapid organic growth, our business model allows for growth through acquisitions and mergers. M&A activity has featured prominently in the company’s recent past. Our broad R&D portfolio covers projects from early research right through clinical trials and on to registration and marketing. Related categories: Pharmaceutical Companies